Jade Biosciences JBIO
NASDAQ JBIO
$16.52 +0.13 (+0.76%)
As of: Nov 11, 2026 · 3:51 PM EST

Jade Biosciences (JBIO) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Jade Biosciences (JBIO) posted Return on Capital Employed [ROCE] of -45.23% for Q2 2026, down 19.31 percentage points from -25.92% a year earlier and down 2.46 percentage points from the prior quarter.

Analysis

Jade Biosciences (JBIO) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Jade Biosciences' Return on Capital Employed [ROCE] came in at -58.30%, up 26.36 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -31.99 percentage points (FY2021 to FY2025).
  • In prior years, Jade Biosciences' Return on Capital Employed [ROCE] was -84.66% in FY2024 (-13.07 pp), -71.59% in FY2023 (-35.51 pp), -36.08% in FY2022 (-9.77 pp) and -26.31% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in six of the last eight quarters, with an average year-over-year change of +19.94 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2025, with a gain of 76.23 percentage points; the weakest was Q2 2024, with a drop of 48.53 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -42.78% (Q1 2026), -43.74% (Q4 2025) and -24.05% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Jade Biosciences 1.04 Bn -265.30 Mn - -45.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -45.23%
Mar 31, 2026 -42.78%
Dec 31, 2025 -43.74%
Sep 30, 2025 -44.52%
Jun 30, 2025 -56.17%
Mar 31, 2025 -97.48%
Dec 31, 2024 -103.25%
Sep 30, 2024 -96.49%
Jun 30, 2024 -102.15%
Mar 31, 2024 -86.99%
Dec 31, 2023 -69.87%
Sep 30, 2023 -56.29%
Jun 30, 2023 -53.62%
Mar 31, 2023 -50.21%
Dec 31, 2022 -39.82%
Sep 30, 2022 -31.71%
Jun 30, 2022 -23.92%
Mar 31, 2022 -18.78%
Dec 31, 2021 -12.99%
Sep 30, 2021 -15.42%
API Access

Jade Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=JBIO&period=max&api_key=YOUR_API_KEY